A recent drug-screening study showed that a combination of NAD+ precursors with mitophagy inducers, urolithin A and actinonin, restored mitophagy and ameliorated cognitive impairment by reducing phospho-tau and Aβ deposition in AD transgenic nematodes and mouse models [163]. Here, MAPT is linked to Alzheimer disease.